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Abstract
Background: Brugia malayi is endemic in several Asian countries with the highest prevalence in
Indonesia. Determination of prevalence of lymphatic filariasis by serology has been performed by
various investigators using different kinds of antigen (either soluble worm antigen preparations or
recombinant antigens). This investigation compared the data obtained from IgG4 assays using two
different kinds of antigen in a study on prevalence of antibodies to B. malayi.
Methods: Serum samples from a transmigrant population and life long residents previously tested
with IgG4 assay using soluble worm antigen (SWA-ELISA), were retested with an IgG4 assay that
employs BmR1 recombinant antigen (BmR1 dipstick [Brugia Rapid™]). The results obtained with
the two antigens were compared, using Pearson chi-square and McNemar test.
Results: There were similarities and differences in the results obtained using the two kinds of
antigen (SWA and BmR1). Similarities included the observation that assays using both antigens
demonstrated an increasing prevalence of IgG4 antibodies in the transmigrant population with
increasing exposure to the infection, and by six years living in the area, antibody prevalence was
similar to that of life-long residents. With regards to differences, of significance is the
demonstration of similar antibody prevalence in adults and children by BmR1 dipstick whereas by
SWA-ELISA the antibody prevalence in adults was higher than in children.
Conclusions: Results and conclusions made from investigations of prevalence of anti-filarial IgG4
antibody in a population would be affected by the assay employed in the study.
Background
Lymphatic filariasis affects approximately 120 million
people worldwide. Ten percent of these infections are
attributed to Brugia malayi and Brugia timori [1]. Thick
blood smear examination is the routine parasitological
method used for diagnosis and prevalence studies in the
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Brugia endemic countries of Malaysia and Indonesia [2,3].
This diagnostic method depends on the detection of
microfilariae in the peripheral blood, and due to the noc-
turnal periodicity of microfilaremia in these areas,
requires nighttime collection and survey, which is often
unpopular with the local population. Furthermore, this
method is relatively insensitive [4] and difficult to per-
form accurately and with consistency in field situations.
Conversely, serological diagnostic methods exhibit better
sensitivity than detection of microfilaria by thick blood
smear, allow the detection of amicrofilaraemic infections
among "endemic normals" and afford daytime finger-
prick blood sampling (thus overcoming the inconven-
iences associated with night blood sampling, thereby
encouraging greater cooperation with the local popula-
tion and facilitate field work) [5].
However, reports on antigen detection test for brugian
filariasis have not demonstrated high levels of sensitivity
[6,7]. Thus in the absence of a good antigen detection test
for Brugia infection, anti-filarial IgG4 assay may be the
next best alternative for detection of brugian filariasis [8].
Anti-filarial IgG4 levels have been demonstrated to be ele-
vated in active filarial infection [9-13] and decline post-
treatment [14-17]. Detection of anti-filarial IgG4 antibod-
ies has also been used for epidemiological assessment of
filariasis [13,18,19].
Studies assessing antibody prevalence of lymphatic filaria-
sis have employed assays that use either soluble worm
antigens or recombinant antigens [12,13,18-21]. These
antigens may not bind to the same set of anti-filarial anti-
bodies and probably display different cross-reactivities to
antibodies against other infections. Thus differences in
the antigens employed may be expected to affect the
results of antibody prevalence studies. Therefore, the
present study aimed to make direct comparison of two
antigens i.e. soluble adult worm antigen (SWA) and a
recombinant antigen (BmR1), in IgG4 assays on the same
set of serum samples.
Previously, an ELISA employing soluble adult worm anti-
gen (SWA-ELISA) had been performed to determine prev-
alence of anti-filarial IgG4 antibodies on a set of serum
samples from Indonesia. These samples were collected
from:
1. A transmigrant population that migrated from a non-
filarial endemic region to an area endemic for Brugian
filariasis and;
2. Life-long residents of the Brugian endemic area [22].
In the present study a rapid test based on B. malayi recom-
binant antigen (BmR1 dipstick [Brugia Rapid™]) and
detection of IgG4 antibodies were evaluated using the
same set of serum samples. The BmR1 dipstick test has
previously been shown to be highly specific and sensitive
for the detection of brugian filariasis. In a study involving
four international laboratories, the BmR1 dipstick was
found to be 93% sensitive and 100% specific when tested
with 535 serum samples from patients with various infec-
tions and healthy controls [8]. In another multicenter val-
idation study, 97% sensitivity and 99% specificity were
recorded when the BmR1 dipstick was tested with 753
serum samples [23].
The present study demonstrated that interpretations of
some aspects of the seroepidemiology of filarial infection
are affected by the kind of antigen employed in the assay.
Thus this study, which utilized the same set of serum sam-
ples on assays using two kinds of antigens, highlights the
role of the kind of antigen employed in the comparison of
results of prevalence studies.
Materials and methods
Sera and study population
The details on the sera and study population are as
described previously [22]. Briefly, serum samples were
collected cross-sectionally from a total of 247 transmi-
grants and 133 life-long residents (LLR) from Budong-
budong, a district of Mamuju Regency in South-Sulawesi,
Indonesia, which is endemic for nocturnal-periodic B.
malayi [24,25]. The samples from the transmigrant popu-
lation are valuable as they could help determine the pat-
tern of acquisition of infection with increasing length of
exposure to Brugian filariasis. The transmigrant popula-
tion had traveled to their new homesteads in groups; they
came from the same village or region in Bali or Lesser
Sunda islands as part of the government-sponsored relo-
cation programme. Each year a new settlement was
founded close to the former one (between 10 and 20 kil-
ometers) which accommodated groups of transmigrants
from 2–3 different regions together with migrants from
Polmas, an over-populated area in South Sulawesi, to pro-
mote integration of different tribes. Transmigrants were
grouped together according to the year of arrival in the
new settlement. A total of 6 transmigrant units, settled
between several months and 6 years prior to the survey,
were included in the study together with 2 villages of
indigenous Sulawesians (LLR), which were situated
closely to the transmigrant areas. Those aged ≤ 15 years
were classified as children, while adults were classified as
those aged 16 years and older. The mean age of children
in transmigrant population and LLR population was 10.2
years and that of adults was 32.6 years.Filaria Journal 2004, 3:8 http://www.filariajournal.com/content/3/1/8
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Soluble worm antigen (SWA)
Adult B. malayi worms were purchased from TRS labs, Ath-
ens, Georgia, USA. Female worms were freeze dried,
ground to powder, dissolved in phosphate buffered saline
(PBS), homogenized and slowly stirred overnight at 4°C.
The protein concentration was determined by 2,2'-biqui-
noline-4,4'-dicarboxylic acid disodium salt hydrate (BCA)
method before storage at -20°C.
BmR1 dipstick
This BmR1 dipstick (Brugia Rapid™) was performed as
described previously and according to the instructions of
the manufacturer [16, Malaysian Bio Diagnostics Research
Sdn. Bhd., Bangi, Selangor, Malaysia]. The BmR1 recom-
binant antigen was expressed from Bm17DIII  DNA
sequence, GenBank accession no. AF225296. Southern
blot hybridization assays performed on cDNA libraries of
L3, L4, mf, adult male and adult female B. malayi demon-
strated that the DNA sequence is present in all of the five
kinds of libraries (Rahmah et al., unpublished data). Pre-
liminary immunohistological studies suggest that the
expressed antigen is found in the epithelial membranes of
the adult female uterus (Rahmah et al., unpublished
data).
Statistical Analysis
The results obtained with BmR1 dipstick were compared
to the results obtained previously with SWA-ELISA. The
similarities and differences in the results were analyzed by
comparing proportion of related samples using McNemar
test; and comparing proportions of unrelated samples by
using Pearson Chi-square (if indicated Fischer exact test
was used instead).
Results and Discussion
Figure 1 shows the antibody prevalence to B. malayi, as
determined by BmR1 dipstick assay and SWA-ELISA, in
the transmigrant population who had resided for various
lengths of time in the endemic area and the antibody
prevalence in the LLR population. The first detection of
IgG4 antibody by the BmR1 dipstick was recorded at 3
years post-exposure, the antibody prevalence increased
from 0% in the new arrivals (≤ 1 month and 2–4 months)
to 7.4%, 11.1%, 39.1% and 42 % in populations exposed
to the infection for 3, 4, 5 and 6 years respectively. Com-
parison of IgG4 assays using the two kinds of antigen
demonstrated similarities in three areas. First, using both
SWA-ELISA and BmR1 dipstick, the total prevalence of
specific IgG4 in the transmigrant population was found to
increase with increasing length of residence in the
endemic area. Thus the BmR1 dipstick test confirmed the
previously reported finding which demonstrated that the
development of anti-filarial IgG4 correlated with the
duration of exposure in previously unexposed population
[22]. Second, after a period of 5–6 years of being exposed
to the filaria infection, anti-filarial IgG4 prevalence by
BmR1 dipstick in the transmigrant population (42%) was
comparable (p = 0.763) to the antibody prevalence in the
LLR population (39.8%); this finding was also previously
reported with SWA-ELISA [22]. Thus the results with
BmR1 dipstick is in agreement with the previous finding
that approximately 5–6 years of exposure is required for
the anti-filarial IgG4 in the transmigrant population to
reach levels comparable to life-long residents. This is also
reported to be the period needed for the detection of
microfilaria in the peripheral blood [22]. Third, the over-
all prevalence of anti-filarial IgG4 was found to be higher
in males than in females, by both BmR1 dipstick (p =
0.019) and by SWA-ELISA (p = 0.001).
Differences between the two kinds of antigen were also
observed (Figure 1). First, except for year 5 transmigrants
(p = 0.146), the percent antibody prevalence recorded in
the transmigrant population and in the LLR population
by BmR1 dipstick were significantly lower than that
detected by the SWA-ELISA i.e. year 3, p = 0.00; year 4, p
= 0.00; year 6, p = 0.041; LLR, p = 0.00. Second, using
SWA-ELISA, anti-filarial IgG4 was first detected at 2–4
months post-exposure in the population of transmigrants,
while using BmR1 dipstick the first detection of IgG4
IgG4 antibody prevalence in transmigrant population who  resided in B. malayi endemic areas for various lengths of time  and in life-long residents (LLR), as determined by BmR1 dip- stick and SWA-ELISA Figure 1
IgG4 antibody prevalence in transmigrant population who 
resided in B. malayi endemic areas for various lengths of time 
and in life-long residents (LLR), as determined by BmR1 dip-
stick and SWA-ELISA.
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antibody was recorded after three years of residence in the
endemic area.
Figure 2a and 2b shows the IgG4 antibody prevalence
among children and adult populations as determined by
BmR1 dipstick and SWA-ELISA respectively. There was no
significant difference detected in antibody prevalence
between adults and children in the transmigrant popula-
tion and in the LLR population when BmR1 dipstick was
used (year 3, p = 0.594; year 4, p = 0.066; year 5, p = 0.907;
year 6, p = 0.061; LLR, p = 0.074). Using SWA-ELISA,
except for early transmigrant settlers (2–4 months resi-
dents), the IgG4 prevalence in the transmigrant popula-
tion was reported to be significantly higher in adults than
in children [22]; however in the LLR population, antibody
prevalence in children was not significantly higher than in
adults (p = 0.316).
Thus the BmR1 dipstick test demonstrated that the estab-
lishment of anti-filarial IgG4 in the children and adults of
the transmigrant population occur at comparable rates;
this is not in agreement with the previous finding, using
SWA-ELISA, that demonstrated IgG4 was established
more rapidly in the adult population than in children
[22]. The above observations may be due to a mixture of
filarial antigens in SWA, some of which may recognize
antibodies produced by exposed but not infected individ-
uals, and/or by individuals who have cleared the infection
either due to treatment or spontaneous death of worms.
Although IgG4 detection significantly increases the
specificity of antibody assays in brugian filariasis [12] the
specificity of parasite extract-based assays and recom-
binant antigen-based assays may not be the same. In a
recent study in a non-filaria endemic area in Brazil, the
presence of Strongyloides antibody responses was found to
be associated with higher antifilarial IgG4 responses in
assay that uses crude filaria extract as compared to assay
that uses B. malayi Bm14 recombinant antigen [26].
The discrepancy between the results of SWA-ELISA and
BmR1 dipstick may also be partly due to the greater sensi-
tivity of the former as compared to the latter. Out of 120
(of 381) discrepant results, 111 were positive by SWA-
ELISA but negative by BmR1 dipstick. Out of these 111
samples, 38 had low ELISA titers (cut-off value > 4.02 but
< 4.5). If the stringency of the cut-off value of the SWA-
ELISA is increased from 4.02 to 4.5, then the discrepancy
can be considerably reduced to 88 (of 381), with 73 posi-
tive by SWA-ELISA but negative by BmR1 dipstick. On the
other hand, since BmR1 dipstick test has been reported to
be highly specific [8,23], it is unclear why there were eight
individuals who were positive by BmR1 dipstick but neg-
ative by SWA-ELISA.
Due to the problem of maintaining the antigenicity of the
BmR1 antigen when shipped from Malaysia to Nether-
lands, the dipstick (immunochromatography) assay,
which can be transported at room temperature, was
employed to test the BmR1 antigen. However the differ-
ence in the assay formats is unlikely to be the reason for
the lower overall antibody prevalence levels seen with the
latter. This is because we have previously shown that
ELISA using BmR1 was less sensitive (albeit equally spe-
cific) than BmR1 dipstick test [27] in detecting B. malayi
infection. Thus in this study if the ELISA format had been
IgG4 antibody prevalence in transmigrant adult and children  populations who resided in B. malayi endemic areas for vari- ous lengths of time and in life-long residents (LLR) Figure 2
IgG4 antibody prevalence in transmigrant adult and children 
populations who resided in B. malayi endemic areas for vari-
ous lengths of time and in life-long residents (LLR).
a (top) IgG4 antibody prevalence as determined by BmR1 
dipstick assay.
b (bottom) IgG4 antibody prevalence as determined by 
SWA-ELISA. (Note: Previously published in Parasitology 
2001; 122, pg. 636 [Reproduced with permission]).
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used to determine prevalence of IgG4 antibodies to BmR1
instead of the dipstick format, the SWA-ELISA would still
be detecting significantly more positives than the BmR1-
ELISA.
Differences between the two antigens were also observed
in the pattern of IgG4 antibody prevalence in children
(Figure 2a &2b). Using BmR1 dipstick, positivity of the
test in children was first demonstrated at 3 years (2 of 35,
5.7%), followed by no positive child detected at year 4 (0
of 17), positive antibody prevalence at year 5 (3 of 8;
37.5%) which is significantly greater than at year 3 (p =
0.011). This is followed by a nonsignificant decrease (p =
0.589) in antibody prevalence by year 6 (6 of 22; 27.3%).
IgG4 prevalence at year 6 and LLR (30 of 87; 34.5%) was
also found to be not significantly different (p = 0.542).
After year 4, the IgG4 prevalence in children seemed to
achieve a stable level that was similar to the antibody
prevalence in the LLR population children. In adults,
infection was also initially detected at year 3 and there
appeared to be a pattern of increasing antibody preva-
lence with increasing time of residence (9.1% at 3 years;
16.7% at year 4, 40% at year 5; 53.6 % at year 6). Further-
more, the detection rate at year 6 was not significantly dif-
ferent (p = 0.766) from that seen in the LLR population
adults (50%). Thus using the BmR1 dipstick, the increas-
ing total IgG4 prevalence with exposure to brugian filaria-
sis was mostly due to the increasing positive cases in the
adult population. It is tempting to speculate that the dif-
ferences in the pattern observed in children and adults are
due to the greater rate of aborted infections and/or spon-
taneous clearance of the infection in children than in
adults. The overall lower worm burden in children, due to
physiological differences, may enable higher rate of spon-
taneous clearance of infections in children than in adults.
The difference in physiology between adults and children
has been demonstrated by the greater number of natural
killer cells, and T-and B-lymphocytes in children as com-
pared to middle aged people [28]. In addition CD4/CD8
T-cells have also been reported to decline from a young
age onwards [29,30]. However, since this is a cross-sec-
tional study in which data for each period of residence
were obtained from different groups of individuals, this
hypothesis could not be confirmed.
Conversely, results of the SWA-ELISA demonstrated initial
antibody positivity in children at 2–4 months, followed
by increasing antibody prevalence with time of residence.
IgG4 prevalence at year 6 was found to be significantly
lower than the antibody prevalence in children of the LLR
population (p = 0.007). In the adult population, except
for the earlier initial detection, a similar pattern was
observed with the results of the BmR1 dipstick i.e. increas-
ing rate of antibody prevalence in the transmigrants with
exposure; and the IgG4 prevalence at year 6 is not signifi-
cantly different (p = 0.430) than the antibody prevalence
in the LLR adult population.
Conclusions
This study highlights that assays using both BmR1 and
SWA antigens demonstrate an increasing prevalence of
specific IgG4 antibodies in the transmigrant population
with increasing length of residence in an area endemic for
brugian filariasis, and, by six years residency that the anti-
body prevalence was similar to that observed in the LLR
population. This study also documented three main dif-
ferences in results derived from assays using two antigens
i.e.
1. Earlier detection and higher rate of antibody prevalence
by SWA-ELISA as compared to the results demonstrated
by BmR1 dipstick;
2. Similar rate of acquisition of antibody prevalence in
children and adults by BmR1 dipstick; whereas by SWA-
ELISA adults were found to become antibody positive
faster than in children;
3. By BmR1 dipstick the increasing total prevalence of
IgG4 with exposure was primarily due to the adult popu-
lation, whereas by SWA-ELISA this was attributed to both
children and adult populations.
This study demonstrates that some aspects of seroepide-
miology of Brugia malayi infection may vary with the kind
of antigen used in the assay. Thus comparison of results of
different studies must take into account the kind of anti-
gen employed, especially if one study uses native antigen
and another uses recombinant antigen. It would be inter-
esting to compare seroepidemiological data of IgG4
assays using two different recombinant antigens on the
same population.
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